Acrivon Therapeutics Inc. (ACRV)
Market Closed
3 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 5100
-0.06
-3.82%
$
52.38M Market Cap
- P/E Ratio
- Div Yield
294,385 Volume
- Eps
$ 1.57
Previous Close Want to track ACRV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ACRV Earnings Reports FAQ
What is the earnings per share (EPS) for ACRV?
EPS data for ACRV is currently not available, as Acrivon Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Acrivon Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Acrivon Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Acrivon Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ACRV at this time, as Acrivon Therapeutics Inc has no recent EPS data to calculate it.
